Title
Drug Safety Data: How To Analyze, Summarize, And Interpret To Determine Risk,New
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Payment Option
Drug Safety Data: How To Analyze, Summarize And Interpret To Determine Risk Was Selected For The First Clinical Research Bookshelf Essential Reading For Clinical Research Professionals By The Journal Of Clinical Research Best Practices.Drug Safety Data: How To Analyze, Summarize And Interpret To Determine Risk Provides Drug Safety/Pharmacovogilance Professionals, Pharmaceutical And Clinical Research Scientists, Statisticians, Programmers, Medical Writers, And Technicians With An Accessible, Practical Framework For The Analysis, Summary And Interpretation Of Drug Safety Data. The Only Guide Of Its Kind, Drug Safety Data: How To Analyze, Summarize And Interpret To Determine Risk Is An Invaluable Reference For Pre And Postmarketing Risk Assessment. With Decades Of Pharmaceutical Research And Drug Safety Expertise, Authors Dr. Klepper And Dr. Cobert Discuss How Quality Planning, Safety Training, And Data Standardization Result In Significant Cost, Time, And Resource Savings. Through Illustrative, Stepbystep Instruction, Drug Safety Data: How To Analyze, Summarize And Interpret To Determine Risk Is The Definitive Guide To Drug Safety Data Analysis And Reporting.Key Features Include:* Stepbystep Instruction On How To Analyze, Summarize And Interpret Safety Data For Mandatory Governmental Safety Reports* Pragmatic Tipsand Mistakes To Avoid* Simple Explanations Of What Safety Data Are Collected, And What The Data Mean* Practical Approaches To Determining A Drug Effect And Understanding Its Clinical Significance* Guidance For Determining Risk Throughout The Lifecycle Of A Drug, Biologic Or Nutraceutical* Examples Of Userfriendly Data Displays That Enhance Safety Signal Identification* Ways To Improve Data Quality And Reduce The Time, Resources And Costs Involved In Mandatory Safety Reporting* Relevant Material For The Required Training Of Drug Safety/Pharmacovigilance Professionals* Special Feature: Actual Examples Of An Integrated Analysis Of Safety (Ias) Used In The Preparation Of The Integrated Summary Of Safety (Iss) And The Summary Of Clinical Safety (Scs) Reports , And The Periodic Safety Update Report (Psur)
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.